Spasmo Proxyvon Forte Injection 2Ml

SPASMO PROXYVON FORTE INJECTION 2ML may interact with the following medicines:

• Anticoagulant medicines such as warfarin: Concurrent use with diclofenac may increase the risk of bleeding and gastrointestinal complications.
• Other NSAIDs such as ibuprofen or naproxen: Combined use may increase the risk of stomach ulcers, bleeding, and kidney-related side effects.
• Anticholinergic medicines such as atropine: Concurrent use with dicyclomine may increase the risk of dry mouth, constipation, blurred vision, and urinary retention.
• Antihypertensive medicines such as amlodipine or enalapril: NSAIDs may reduce the blood pressure-lowering effect of these medicines and increase the risk of kidney impairment, especially in dehydrated or older patients.
• Corticosteroids such as prednisolone: Combined use may increase the risk of gastrointestinal irritation, ulcers, or bleeding.

SPASMO PROXYVON FORTE INJECTION 2ML may interact with diseases/conditions, including:

• Peptic ulcer or gastrointestinal bleeding: Diclofenac may increase the risk of stomach ulcers, bleeding, or perforation in susceptible individuals.
• Asthma: Some patients with asthma may experience worsening breathing difficulty or bronchospasm after taking NSAIDs.
• Glaucoma: Dicyclomine may increase intraocular pressure and worsen symptoms in patients with glaucoma.
• Prostatic enlargement: Anticholinergic effects of dicyclomine may worsen urinary retention in susceptible individuals.
• Intestinal obstruction: Dicyclomine may reduce gut movement and worsen symptoms such as abdominal swelling, pain, constipation, or blockage in patients with intestinal obstruction.
• Myasthenia gravis: Dicyclomine may worsen muscle weakness and increase the risk of difficulty in swallowing, speaking, or breathing in patients with myasthenia gravis.
• Severe ulcerative colitis: Dicyclomine may reduce intestinal motility and increase the risk of severe bowel complications such as paralytic ileus or toxic megacolon in patients with severe ulcerative colitis.

The dose and frequency of SPASMO PROXYVON FORTE INJECTION 2ML should be determined by your doctor based on the severity of symptoms, medical condition, and treatment response. Do not alter the prescribed dose without consulting your doctor.

An overdose of SPASMO PROXYVON FORTE INJECTION 2ML is unlikely to occur as it is administered by a healthcare professional.

If you miss a scheduled dose of SPASMO PROXYVON FORTE INJECTION 2ML, contact your doctor or healthcare provider to reschedule the injection.